Four in five Aussie asthma sufferers to breathe easier under new technology
/in Adherium, BioScience Managers, Portfolio CompaniesFour in five Aussie asthma sufferers to breathe easier under new technology Tuesday, 29 April 2025 More than 2.2 million Australian people with asthma could benefit from life-changing digital inhaler technology which has the potential to save lives and ease the burden on Australia’s strained healthcare system. Approximately 2.8 million Australians have a diagnosis […]
Trump tariffs hit ASX as Australian businesses assess costly fallout
/in BioScience ManagersTrump tariffs hit ASX as Australian businesses assess costly fallout This article is originally written and posted the Australian Financial Review. Dozens of major Australian companies will face higher costs and lower sales after the outbreak of a debilitating trade war between the United States and its closest partners, with exporters scrambling to evaluate […]
Announcement: Saluda Medical Announces Closing of $100 Million Financing
/in BioScience Managers, Saluda MedicalThe Future of Medicine with Jeremy Curnock Cook and his vision for BioScience Managers
/in BioScience ManagersCritical to support innovation – We need to strike while the iron is hot, writes Jeremy Curnock Cook
/in BioScience ManagersJeremy in Türkiye as a guest at the Foreign Economic Relations Board (DEIK)
/in BioScience Managers“Jeremy Curnock-Cook, the world-famous name in the field of Biotechnology, was our guest – evaluating developments and investment opportunities in the field of new-generation technology.” From Erdem Erkul, CEO of Cerebrum Technologies, and Chairperson of Digital Technologies Business Council of DEIK. LinkedIn post Caner Çolak, Secretary General of DEIK Erdem Erkul, CEO of Cerebrum Technologies […]
Air supply: The ASX medtechs tackling respiratory illnesses
/in BioScience ManagersPic via Getty Images LINK HERE | August 14, 2024 | Nadine McGrath ANDHealth says the Covid-19 pandemic triggered far-reaching changes to Australia’s health system and how we manage respiratory illnesses Lumos Diagnostics has developed FebriDx to helps doctors quickly differentiate a viral from bacterial acute respiratory infection Adherium is focused on improving medication compliance […]
Adherium announces production & market release of new, next-gen sensors
/in Adherium, BioScience ManagersLink Here Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote patient monitoring and data management solutions, is pleased to announce that it has commenced production and market release of the new, next generation Hailie® sensors with physiological parameters connecting GlaxoSmithKline (GSK) Ventolin®, Advair®/Flixotide® and Flovent®/Seretide® inhalers for monitoring Asthma […]
Armata Pharmaceuticals Announces First Patient Dosed in the Phase 2a Portion of the Phase 1b/2a ‘diSArm’ Study of AP-SA02 in Adults with Bacteremia Due to Staphylococcus aureus
/in BioScience ManagersInitiation of the Phase 2a portion follows DRC review of positive safety and tolerability data from recently completed Phase 1b portion Study being conducted in partnership with the U.S. Department of Defense LOS ANGELES, Sept. 26, 2023 /Link here/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for […]
© BioScience Managers, all rights reserved